ClinicalTrials.gg
CompletedNCT07825740Acute & BloodUpdated Sep 17, 2026

Examination of Certain Blood Parameters Following Performance and Acute Exercise at Specific Times of the Day

An interventional study of Standardized Acute Exercise Protocol in Exercise, Physical Performance and Circadian Rhythm, sponsored by Firat University. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-17.

Sponsored by Firat University · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Nov 2025, registered Jul 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Not applicable
Ages
18 Years to 25 Years
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 10 studies in Motor Activity by Firat University — 4 open to participants now, 4 under way, none of them phase 3. Motor Activity · Firat University.

Started
2025
the only one that year
No phase
8 of 10
4 open now
Registered
10th of 10
by date

Among the 10 studies in Motor Activity by Firat University, this one is the only one that started in 2025, is one of 8 with no phase, and was the 10th registered.

Motor Activity

9,798 studies on the registry are indexed under Motor Activity; 1,910 are open to participants now.

Browse Motor Activity studies →

Open to participants now

4 of the 10 studies in Motor Activity by Firat University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 1,201 Motor Activity studies recruiting now, 517 (43%) set no upper age limit and 535 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 18 Years to 25 Years · male · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Motor Activity by Firat University, or all of them as a file.
02

Study summary

This study aims to investigate whether the time of day at which acute exercise is performed influences physical performance and acute hormonal and biochemical responses in healthy young male soccer players. Participants will complete the same standardized exercise protocol in the morning (08:00-09:30) and evening (17:00-18:30), with a 96-hour interval between sessions. Performance will be assessed using vertical jump and Yo-Yo shuttle run tests. Blood samples will be collected before exercise, immediately after exercise, and two hours after exercise to assess testosterone, cortisol, creatine kinase, AST, ALT, LDH, and troponin levels. The study will examine whether exercise responses differ between morning and evening sessions and whether these differences are consistent with circadian variation.

Read the detailed description

The purpose of this study is to examine the acute effects of exercise performed at different times of the day on physical performance, hormonal responses, and biochemical markers associated with exercise-induced muscle stress and recovery in healthy young male soccer players.

The study uses a single-group, repeated-measures pre-test/post-test design in which the same participants complete an identical standardized exercise protocol on two separate occasions. One exercise session will be performed in the morning between 08:00 and 09:30, and the other will be performed in the evening between 17:00 and 18:30. The two experimental sessions will be separated by 96 hours (4 days) to reduce the influence of the preceding exercise session on subsequent measurements.

Before each exercise session, participants will undergo anthropometric assessment and provide a resting blood sample. Participants will then complete standardized physical performance assessments, including a vertical jump test and a Yo-Yo shuttle run endurance test. Immediately after completion of the exercise protocol, a second blood sample will be collected. A third blood sample will be collected two hours after exercise to assess the early recovery response.

Blood samples will be analyzed for hormonal and biochemical parameters, including testosterone and cortisol as hormonal markers, and creatine kinase (CK), aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH), and troponin as biochemical markers of exercise-related physiological and metabolic responses.

The primary purpose of the comparison is to determine whether the acute physiological responses to the same exercise stimulus differ according to the time of day. The study will also explore the potential relationship between exercise timing and circadian variation in physical performance, hormonal responses, and biochemical markers.

All participants will complete the same exercise and measurement procedures under standardized conditions. The study population consists of healthy male soccer players who regularly participate in sports. Participants must be physically able to safely complete the exercise and assessment protocols and must not have medical or musculoskeletal conditions that could affect exercise performance or the safety of the study procedures.

This study is designed to provide information about the influence of exercise timing on acute performance and physiological responses and may contribute to the development of time-of-day considerations in exercise programming and sports training.

03

Conditions studied

  • Exercise
  • Physical Performance
  • Circadian Rhythm

Browse trials for

Keywords

  • Exercise1, Cortisol2, Creatine Kinase3, Circadian Rhythm4, Testosterone5,
04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Eligibility criteria

  • Healthy male soccer players.
  • Age between 18 and 25 years.
  • Regular participation in organized soccer training.
  • Free from musculoskeletal injury during the previous 6 months.
  • Able and willing to provide written .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
8 participants (actual)

Study arms

  • Experimental
    Healthy Male Soccer Players

    Healthy male soccer players participated in a single-group intervention study. All participants completed the same standardized acute exercise protocol twice, once in the morning (08:00-09:30) and once in the evening (17:00-18:30), separated by 96 hours. Performance tests (vertical jump and Yo-Yo shuttle run) and blood samples were obtained before exercise, immediately after exercise, and 2 hours after exercise to evaluate hormonal and biochemical responses.

    Behavioral: Standardized Acute Exercise Protocol

Interventions

  • BehavioralStandardized Acute Exercise Protocol

    Participants completed a standardized acute exercise protocol consisting of a vertical jump test and a Yo-Yo shuttle run endurance test. The protocol was performed twice, once in the morning (08:00-09:30) and once in the evening (17:00-18:30), with a 96-hour washout period between sessions. Blood samples were collected before exercise, immediately after exercise, and 2 hours after exercise to assess hormonal (testosterone and cortisol) and biochemical (CK, AST, ALT, LDH, and troponin) responses.

06

What researchers measure

Primary outcomes

  1. Yo-Yo Shuttle Run Performance

    Change in endurance performance measured by the Yo-Yo shuttle run test following the standardized acute exercise protocol performed in the morning and evening.

    Time frame: Immediately after completion of the exercise performance assessment during each experimental session.

Secondary outcomes

  1. Vertical Jump Performance

    Explosive lower-extremity performance will be assessed using the vertical jump test during the morning and evening experimental sessions.

    Time frame: Baseline (pre-exercise), immediately post-exercise, and 2 hours post-exercise.

  2. Serum Testosterone Concentration

    Serum testosterone concentration will be assessed from blood samples collected before exercise, immediately after exercise, and 2 hours after exercise during the morning and evening experimental sessions.

    Time frame: Baseline (pre-exercise), immediately post-exercise, and 2 hours post-exercise.

  3. Serum Cortisol Concentration

    Serum cortisol concentration will be assessed from blood samples collected before exercise, immediately after exercise, and 2 hours after exercise during the morning and evening experimental sessions.

    Time frame: Baseline (pre-exercise), immediately post-exercise, and 2 hours post-exercise.

  4. Serum Creatine Kinase (CK) Concentration

    Serum creatine kinase concentration will be assessed as a biochemical marker of exercise-related physiological response using blood samples collected before exercise, immediately after exercise, and 2 hours after exercise.

    Time frame: Baseline (pre-exercise), immediately post-exercise, and 2 hours post-exercise.

  5. Serum Aspartate Aminotransferase (AST) Concentration

    Serum AST concentration will be assessed from blood samples collected before exercise, immediately after exercise, and 2 hours after exercise during the morning and evening sessions.

    Time frame: Baseline (pre-exercise), immediately post-exercise, and 2 hours post-exercise.

  6. Serum Alanine Aminotransferase (ALT) Concentration

    Serum ALT concentration will be assessed from blood samples collected before exercise, immediately after exercise, and 2 hours after exercise during the morning and evening sessions.

    Time frame: Baseline (pre-exercise), immediately post-exercise, and 2 hours post-exercise.

  7. Serum Lactate Dehydrogenase (LDH) Concentration

    Serum LDH concentration will be assessed from blood samples collected before exercise, immediately after exercise, and 2 hours after exercise during the morning and evening sessions.

    Time frame: Baseline (pre-exercise), immediately post-exercise, and 2 hours post-exercise.

  8. Serum Troponin Concentration

    Serum troponin concentration will be assessed from blood samples collected before exercise, immediately after exercise, and 2 hours after exercise during the morning and evening experimental sessions.

    Time frame: Baseline (pre-exercise), immediately post-exercise, and 2 hours post-exercise

07

Study locations

1 site
  • MUNZUR University
    Tunceli, 62100, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be made available to other researchers. The study dataset will be used for the purposes described in the study protocol and will not be shared at the individual participant level.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2025 to primary completion in Dec 2025, 0 months.

Of 5,147 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's 0 months is below that.

Counting every sponsor, half of 5,207 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 8, 2026
First posted
Sep 17, 2026
StartActual
Nov 25, 2025
Primary completionActual
Dec 15, 2025
CompletionActual
Jan 15, 2026
Last update
Sep 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07825740
Lead sponsor
Firat University
Responsible party
Baha Engin ÇELİKEL (ASSOCIATE PROFESSOR, Firat University) — Principal investigator
First posted
Sep 17, 2026
Start date
Nov 25, 2025
Primary completion
Dec 15, 2025
Completion
Jan 15, 2026
Last update
Sep 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion